Organigram reports $90M net loss, delayed value-priced pot hurts sales
Organigram (OGI.TO)(OGI) missed analyst expectations in its third quarter as a reduced workforce delayed the launch of the company’s first value-priced pot products, weighing on sales as bargain-seeking consumers purchased from rivals.
The Moncton, N.B.-based cannabis